Could CAR T-Cells tame tough lupus? tiny trial aims to find out
NCT ID NCT07432334
First seen Jun 25, 2026 · Last updated Jul 10, 2026 · Updated 4 times
Summary
This early-stage trial will test whether a personalized immune cell therapy called CAR T-cells is safe for 8 adults with severe lupus that hasn't improved with standard treatments. Participants will receive a single infusion of their own genetically modified cells after a short course of chemotherapy. The main goal is to check for side effects, but researchers will also look for signs that the treatment might help control the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CD19-targeted CAR T-cells (a type of immune cell therapy made from the patient's own blood cells)
- What this could lead to
- If it works, this could point toward a new way to control severe lupus that hasn't responded to standard treatments, potentially reducing or eliminating the need for long-term immunosuppressants.
- What could go wrong
- This is a very early phase 1 trial with only 8 people, so it's mainly checking safety, not effectiveness. CAR T-cell therapy can cause serious side effects like cytokine release syndrome or nerve problems, and it's unknown if it will work for lupus at all.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY LUPUS NEPHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Vinmec Research Institute of Stem Cell and Gene Technology
RECRUITINGHanoi, 10000, Vietnam
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immune cell shot aims to tame tough lupus cases
- Lupus patients get hope from Cancer-Fighting cell therapy
- Lupus patients may get new hope from In-Body cell therapy
- Immune cell therapy shows promise for Tough-to-Treat lupus
- Engineered immune cells take on lupus, scleroderma, and Sjogren's
- CAR T-Cell therapy: what happens years later?